Pharmaceutical Executive April 10, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses how access to these weight loss drugs can help the obesity epidemic.

Access is always a big topic for us. So how can access to these weight loss drugs help the obesity epidemic that not only the US is facing, but the world?

You hit the issue. The issue isn’t that we don’t have medications available today. The issue is that we have chosen not to make them accessible for the average patient. If you have a Cadillac health plan, or you’re very wealthy, you can get all the care you need. But if you are the normal person out there suffering from obesity, the coverage is blocked....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Trends
Pepper Bio spices up pipeline with $135M deal for G1 Therapeutics' CDK4/6 inhibitor
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threats
Lilly uses Mounjaro millions to hunt for biotech partners
FTC cracks down on drug patents
Methods To Alter Cellular Gene Expression

Share This Article